ArticleBrain & spine2026
A new hernia blocking system prevents lumbar disc herniation recurrence and disc degeneration: 2 years results of a multicentric clinical investigation.
Article in Brain & spine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04188236 (A Multi-center, Prospective Study to Evaluate the Safety and Performance of a Hernia Blocking System to Prevent Recurrent Lumbar Disc Herniation), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Multi-center, Prospective Study to Evaluate the Safety and Performance of a Hernia Blocking System to Prevent Recurrent Lumbar Disc Herniation
Who cites it
2 citing papers in PubMed.
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Recurrent lumbar disc herniation (rLDH) is a common complication of limited discectomy for patients with large annular defects. This manuscript presents the first long-term experience with a new hernia blocking system (HBS) that aims to reduce rLDH. Research question: Whether a new HBS, implanted after a limited discectomy, prevents rLDH. Material and methods: Thirty patients with a postero-lateral disc herniation between L4 and S1 and large annular defects, who underwent a limited discectomy and were treated with a new HBS (DISC care, NEOS Surgery S.L.), were included in the study. Patients were clinically evaluated with patient questionnaires (VAS Pain and Oswestry Disability Index - ODI) and neurological examinations and radiologically evaluated with MR, CT scan and X-Rays before surgery to assess preoperative status and at 6 weeks, 6, 12 and 24 months after surgery to assess their progression. Results: No symptomatic rLDH was detected during the 24-months follow-up. Additionally, disc height was largely preserved, and no disc degeneration was observed in the studied patients. All patients had a significant reduction in leg pain (>2 points in the NRS) and 84.6 % improved >15 points in the ODI. The implantation of the HBS was not associated with segmental instability, vertebral body fractures, heterotopic ossification or spontaneous fusion. No product-related serious adverse events nor secondary surgical interventions occurred. Discussion and conclusions: The implantation of this new HBS is an easy and safe procedure that prevents long-term rLDH. Clinicaltrialsgov: NCT04188236.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.